Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1/2 × Withdrawn × FED × Clear all

Phase

Phase NA 3 Phase 1/2 2 Phase 2/3 1 Phase 1 1

Status

Completed 3 Withdrawn 2 Recruiting 2 Not yet recruiting 1

Sponsor Class

OTHER 191 INDUSTRY 97 NIH 15 NETWORK 5 OTHER_GOV 2 FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

poly ICLC 1 copanlisib 1 avelumab 1 Immunoglobulins, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

VA Office of Research and Development

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT06064279 2024-09-19

HAITEN-ICI

VA Office of Research and Development

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡